At the heart of the canonical Wnt signaling cascade, APC, axin and GSK3 constitute the so called destruction complex which controls the stability of β-catenin. It is generally believed that four conserved Ser/Thr residues in the Nterminus of β-catenin are the pivotal targets for the constitutively active serine kinase GSK3. In cells that do not receive Wnt signals, GSK is presumed to phosphorylate β-catenin, thus marking the latter for proteasomal degradation. Wnt signaling inhibits GSK3 activity. As a consequence, β-catenin would no longer be phosphorylated and accumulate to form nuclear complexes with TCF/LEF factors. Although mutations in or near the N-terminal Ser/Thr residues stabilize β-catenin in several types of cancer, the hypothesis that Wnt signaling controls phosphorylation of these residues remains unproven. We have generated a monoclonal antibody, which recognizes an epitope containing two of the four residues when both are not phosphorylated. The epitope is generated upon Wnt signaling as well as upon pharmacological inhibition of GSK3 by lithium, providing formal proof for the regulated phosphorylation of the Ser/Thr residues of β-catenin by Wnt signaling. Immunohistochemical analysis of mouse embryos utilizing the antibody visualizes sites that transduce Wnt signals through the canonical Wnt cascade.
Introduction
Wnt signal transduction controls multiple developmental events throughout the animal kingdom. Wnt/wingless proteins constitute a large family (> 19 members in human) of secreted cysteine-rich glycoproteins. Wnts function as ligands for a receptor complex consisting of one of several members of the Frizzled (Fz) family of serpentine receptors 1 and of LRP-5/6, homologues of the LDL receptor [2] [3] [4] . β-catenin participates in a large cytoplasmic protein complex, containing the serine/threonine protein kinase glycogen synthase kinase-3 (GSK-3), the tumor suppressor gene product APC (adenomatous polyposis coli) and axin/conductin [5] [6] [7] [8] . In the absence of Wnt, GSK-3 9;10 is constitutively active, and is believed to promote degradation of β-catenin by N-terminal phosphorylation and subsequent ubiquitination and proteasomal targeting 11;12 . In response to Wnt, the activity of GSK-3 is inhibited by an incompletely understood mechanism. As a consequence, β-catenin's breakdown is suppressed 13 . Indeed, oncogenic mutations in β-catenin at putative GSK-3 phosphorylation sites stabilize β-catenin in colorectal cancer and melanoma 14 , causing aberrant activation of TCF 14;15 . Interspecies sequence comparison of β-catenin as well as the oncogenic point mutations in β-catenin have implied four N-terminal residues as the targets of upstream kinases: Ser33, Ser37, Thr41 and Ser45 (for an overview: see URL www.ana.ed.ac.uk/rnusse/pathway/bcatmut.html). To date however, no biochemical data exist to confirm the regulated phosphorylation of these residues. Such analyses are complicated by the fact that two separate pools of β-catenin co-exist in epithelial cells. Independent of the pool of labile, APC-bound β-catenin, a much larger, highly stabile pool of β-catenin is tightly bound to the cytoplasmic tail of cadherin-type adhesion molecules. This second pool effectively links cadherins to the actin cytoskeleton [16] [17] [18] . To provide formal biochemical proof for the regulated phosphorylation of β-catenin during Wnt signaling, we have developed a monoclonal antibody, αABC (α-active β-catenin), which recognizes non-phosphorylated Ser37 and Thr41. We show that the antibody visualizes the generation of active β-catenin by the canonical Wnt pathway during murine embryogenesis.
Materials and Methods

Cell lines and reagents
The 293T cell line was cultured in RPMI, complemented with 10 % fetal calf serum, penicillin and streptomycin. ALLN ( N-acetyl-Leu-Leu-norleucinal) was obtained from Sigma, LiCl from Riedel de Haen.
Generation of an α-active β-catenin (αABC) antibody
A 300 bp PCR product encoding the first 100 amino acids of human β-catenin protein was cloned into pET21a prokaryote expression vector [Novagen] and used to generate His-tagged recombinant protein in BL21 E. coli. Six week old BALB/c mice were immunized with 200 µg of purified β-catenin(1-100) fusion protein in Freund's complete adjuvant [Difco] , with a second injection in Freund's incomplete adjuvant [Difco] 14 days later. Following sacrifice of immunized mouse, the splenocytes were fused to SP2/0 mouse myeloma cells using polyethylene glycol. The fused cell population was resuspended in hypoxanthine aminotropterin thymidine selection medium [Life] and plated into 96-well flat bottom culture plates. Hybridoma supernatants were screened by immunochemical staining of methanol-fixed COS cells transfected with human β-catenin. The â-catenin N-terminal deletion contructs were generated in pCDNA3neo [ Invitrogen] by polymerase chain reaction (PCR) and subcloned in the pGEM-T vector [ Promega] . The following primers were used: WTmyc 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GAT GGC TAC TCA AGC TGA TTT G, ∆26 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GCA ACA GTC TTA CCA CCT GGA CTC T, ∆31 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GGA CTC TGG AAT CCA TTC TGG T, ∆35 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GCA TTC TGG TGC CAC TAC CAC A, ∆39 5': CCA AGG ATC ACC ATG GAG CAG AAG CTG ATC AGC GAG GAG GAC CTG ACT ACC ACA GCT CCT TCT CTG, ∆43 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GCC TTC TCT GAG TGG TAA AGG C, ∆48 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GAA AGG CAA TCC TGA GGA AGA G, ∆60 5': CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GCA AGT CCT GTA TGA GTG GGA A, ∆ 3': CGG TTG CCT CGA GTC ATT GCA TAC TGT CCA TC. The construction of pCIneo-S33Y-β-catenin and pCIneo-∆45 β-catenin, encoding a β-catenin molecule with an S to Y substitution or a deletion of amino acid S45, was described previously 14 . 10 6 Cos cells were transfected with 1 µg of the β-catenin constructs using DEAE Dextran and fixed in methanol after 2 days. After rinsing the plates, the cells were incubated with the supernatants of the hybridomas for 60 min, followed by the peroxidase labeled Rabbit-α-Mouse 1:100 [DAKO] for 30 min and AEC/H 2O 2. Pepscan analyses were performed by Pepscan BV., Lelystad, The Netherlands
Peptide ELISA Covalink ELISA plates [ Nunc] were activated by incubating with 100 µl 10 mM SPDP (3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester) [Sigma] in PBS for 30 min at 37°C. The peptides used, were S33P: CQQSYLD S(-P) GIHSG, S37P: CLDSGIH S(-P) AGTTT and T41P: CIHSGAT T(-P) TAPSL. 10 µM peptides in 0.1 M Tris-HCl, pH 8.0 were directly coupled to the bivalent linker via the N-terminal cystein residue for 60 min at 37°C. The coated plates were blocked with PBS/0.25% BSA during 15 min. The monoclonal antibodies were allowed to bind for 45 min at 37°C followed by the secondary antibody Rabbit α-Mouse peroxidase labelled [DAKO] for 30 min at 37°C. The staining was visualized by adding ABTS (2',2'-Azino-Bis(3-Ethylbenzthiazoline-6-Sulphonic Acid) Diammonium, Boehringer)/H 2O 2 and measuring the absorbance at 405 nm.
Western Blots
For detection of endogenous β-catenin protein, 10 6 sample cells were directly lysed in 200 µl of hot 2X SDS-PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% β-MeOH), 
Immunohistochemistry
Mouse embryos were harvested between time points E10.5 and E16.5 days, and fixed in formalin at 4°C. They were subsequently embedded in paraffin and sectioned at 5 µm thickness. After deparaffination, endogenous peroxidase activity was blocked by incubating the sections in 1.5% peroxide in methanol for 20 minutes. The sections were then boiled in 0.01 mol/L citrate buffer, pH 6.0, for 20 minutes and cooled slowly. Before staining, the sections were blocked with Rodent Block [Labvision] for 60 minutes. The sections were washed in phosphate buffered saline (PBS) and incubated with hybridoma culture supernatant of αABC or with the TL pan-β-catenin antibody [Transduction Laboratories Inc.] diluted 1:100 in culture medium for 60 minutes. The sections were washed in PBS and the primary antibody was detected with Poly-HRP-goat-α-mouse IgG [Immunovision] and DAB solution.
Results and Discussion
Generating the dephospho-specific α α ABC antibody To generate a monoclonal antibody against dephosphorylated β-catenin, recombinant protein consisting of the N-terminal 100 amino acids of β-catenin was produced in E. coli and used for mouse immunizations. In two fusion experiments, a total of 16 hybridomas were isolated that recognized full-length human β-catenin when overexpressed in COS cells (Fig 1A) . To map the epitopes recognized by these relevant monoclonal antibodies, we made a series of myc-tagged N-terminal deletion constructs (∆26, ∆31, ∆35, ∆39, ∆43, ∆48 and ∆62; numbered for the first amino acid of β-catenin to be expressed). These constructs were transfected into COS cells. Immunohistochemical stainings revealed that 2 hybridomas recognized epitopes coinciding with the region harboring the regulatory Ser/Thr residues (data not shown). This region comprises the potentially phosphorylated residues Ser33, Ser37, Thr41 and Ser45. Pepscan analysis was independently performed utilizing sequentially overlapping 12-mer peptides covering aminoacid 1 to 52 of β-catenin. This allowed the precise mapping of the epitopes recognized by all 16 antibodies. The Pepscan data of the antibody 8E7, pertinent to this study, are depicted in Fig 1B. The minimal epitope of the antibody as determined by PEPScan comprised HSGATTTAP (residues 36 to 44). The epitope identity was confirmed by transfecting Cos cells with expression constructs encoding several point mutants of β-catenin. The antibody neither bound the S37A mutant, nor the T41D mutant of β-catenin. Aminoacid substitutions at position S33 or S45 had no effect on antibody binding (Fig. 2) . Next, a phospho-peptide ELISA was used to evaluate the influence of individual phosphorylation of the four Ser/Thr residues on antibody recognition. Interestingly, a phosphate group at either Ser37 or Thr41 prevented the binding of this monoclonal antibody to its epitope (Fig. 1C) . A) The N-terminal sequence of β-catenin, amino acids 14 to 50 is depicted. The black boxes indicate the minimal binding epitopes of individual monoclonal antibodies named below each box. as determined by Pepscan analysis. B) The Pepscan analysis for the antibody 8E7 (renamed αABC), is given as an example. From the overlapping sequences of the bound peptides the minimal epitope of the antibody was deduced to be H36-A43 encompassing the putative GSK targets, S37 and T41. C) Phosphorylation of either S37 ("S37P") or T41 ("T41P") abrogated binding of αABC (8E7), but the epitope was restored upon dephosphorylation by CIP treatment. S33P, a phosphorylated peptide not spanning the αABC epitope, was used as a negative control.
Upon dephosphorylation of the phosphorylated peptides with calf intestine phosphatase the binding was restored. We tentatively named the antibody "anti-active β-catenin (αABC)" and concluded that it recognizes an epitope containing Ser37 and Thr41 residues only when both are dephosphorylated. Wnt signaling controls the phosphorylation status of the N-terminal regulatory residues of β β -catenin We then sought to address whether Wnt signaling could generate the αABC epitope. The accumulation of β-catenin levels was provoked in four different ways in 293T cells. Wnt-1 was transiently transfected into these cells, presumably activating Wnt signaling in an autocrine as well as a paracrine fashion. As a positive control, cells were transfected with a β-catenin construct encoding a dominant-positive mutant of β-catenin (∆45-β-catenin), i.e. lacking one of the critical regulatory residues 14 . Two different pharmacological treatments have been described to stabilize β-catenin. LiCl is presumed to mimick Wnt-signaling by the inhibition of GSK3 activity 19 . LiCl is predicted to lead to the accumulation of non-phosphorylated, non-ubiquitinated β-catenin. The proteasomal inhibitor peptide ALLN is predicted to induce the accumulation of phosphorylated, ubiquitinated β-catenin 12 . 293T cells were treated for 6 hrs with these inhibitors. All samples were analyzed by Western blotting, stained with either the C-terminal pan-β-catenin antibody (TL) or with αABC. The pan-β-catenin antibody showed an increase in β-catenin levels under all conditions (Fig. 3, top panel) . Notably, treatment of the cells with ALLN led to an increase in overall β-catenin levels, due to the appearance of higher molecular weight, ubiquitinated forms of β-catenin. The αABC antibody showed similarly increased levels of dephosphorylated β-catenin upon addition of Wnt-1, ∆45-β-catenin and LiCl. However, no increase of the αABC signal was observed upon addition of ALLN (Fig. 3, bottom panel) . This indicated that the increased signal obtained with the other stimuli was not merely a result of quantitative affinity differences. Rather, the αABC antibody unequivocally visualized the presence of β-catenin that is not modified at the regulatory residues S37 and T41. Moreover, the ubiquitinated bands that appeared upon ALLN treatment did not stain with the αABC antibody. This proved the notion that phosphorylation of β-catenin precedes ubiquitination. To confirm that the N-terminal modification of β-catenin indeed represented a phosphorylation event, we performed the following experiment. 293T cells were treated with LiCl or ALLN for 6 hrs, after which the samples were split. Half of the samples were incubated with calf intestine phosphatase. Subsequently, Western blotting was performed with the TL or αABC antibody. Significantly, the signal detected by the αABC antibody, but not the TL antibody, increased in the untreated control sample upon dephoshophorylated with CIP (Fig.4 lanes 1  and 4) . In addition, the ALLN treated cells not only showed a specific increase of αABC signal upon dephosphorylation, but a higher, presumably ubiquitinated band appeared upon CIP treatment (lanes 3 and 6) . The αABC signal from LiCltreated samples were much less affected by CIP treatment, in concordance with the notion that LiCl should itself lead to an accumulation of nonphosphorylated β-catenin (lanes 2 and 5). Taken together, these experiments provide formal proof that Wnt signaling induces the accumulation of β-catenin, not phosphorylated at the N-terminal regulatory residues S37 and T41. Visualization of activated β β -catenin during embryonic development To further demonstrate the physiological function of β-catenin phosphorylation we examined the generation of S37/T41-dephosphorylated β-catenin at defined sites during murine embryonic development. Our insights into the role of the canonical Wnt cascade during mammalian development stem largely from phenotypic analyses of transgenic/knockout mouse models in which expression of various components of the cascade is manipulated. The canonical Wnt cascade activated by Wnt/Fz interactions involves the destruction complex, β-catenin and TCF. However, Wnt/Fz interactions can activate other parallel signaling pathways. In insects, Wnt signaling activates the planar polarity pathway which deviates downstream of Dishevelled to a MAP kinase cascade 20 .
No vertebrate counterpart of this pathway has been described as yet. Moon and colleagues have described a vertebrate Wnt/Fz-activated pathway that involves protein kinase C and Ca ++ mobilization 21;22 . Genetic analyses of Wnt and Fz genes by gene disruption have generally yielded dramatic phenotypic abnormalities, yet do not reveal which downstream pathway is involved. Genetic manipulations of genes encoding downstream components of the canonical pathway, such as the TCFs, do provide such insights.
Previous studies in Tcf4 -/-mice have indicated that the formation of the crypt progenitor compartment in the small intestine is fully dependent on the presence of Tcf-4. While the transition of intestinal endoderm into epithelium proceeds normally in the absence of Tcf-4, no proliferative compartments are maintained in the prospective crypt regions of the small intestine 23 . Thus, an epithelium results which is completely composed of differentiated, nonproliferating enterocytes and goblet cells. This phenotype indicates that a Wnt signal, most likely emanating from sub-epithelial stromal cells, activates a canonical Wnt cascade in crypt epithelial cells, culminating in the activation of TCF target genes by β-catenin/Tcf4 complexes.
Since the Tcf-4 phenotype first becomes visible at E16.5, we analyzed sections of E16.5 embryos by αABC staining, and compared these to sections stained with the pan-β-catenin antibody (Fig. 5A) . While the latter antibody prominently stained the adhesion junctions of villus and crypt regions alike (left panel), αABC staining was weaker and restricted to the cytoplasm and nuclei of cells in the prospective crypts (right panel). This indicated that the canonical Wnt pathway was activated specifically in the prospective crypt cells as predicted, and validated αABC staining as a tool to visualize activity of the canonical Wnt pathway. Gene disruption of another TCF family member, Lef-1, affects the late embryonic development of several structures including teeth, whiskers, hair, and mammary glands 24 . In accordance with the activity of the canonical Wnt pathway in these structures, active β-catenin could readily be detected in the ectodermal parts of the prospective toothbuds on day 12.5 after gestation (Fig. 5B) . The same held for the follicles of the whiskers (from day 13.5 onward, Fig. 5C ) and the ectodermal sites of mammary gland formation (day 16.5, Fig. 5D ). In this study, we provide formal evidence for the notion that, in the absence of Wnt signaling, the N-terminus of β-catenin is phosphorylated prior to its ubiquitination and degradation. Furthermore, we show that Wnt signaling as well as the inhibition of GSK3 lead to the accumulation of dephosphorylated β-catenin. We specifically demonstrate these phosphorylation events with the use of a novel monoclonal antibody, which recognizes an epitope containing two of the four proposed regulatory residues in β-catenin when both are nonphosphorylated. Furthermore, we demonstrate that the antibody visualizes sites that transduce Wnt signals through the canonical Wnt cascade during embryogenesis. Since Wnt/Fz interactions have been demonstrated to activate several different signal transduction cascades, the antibody may be instrumental in outlining those signaling events that activate the canonical pathway.
